You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDO-Inhibitor

Showing 1 - 25 of 7,409
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)

Terminated
  • Non-small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Apr 4, 2022

Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

Active, not recruiting
  • Endometrial Adenocarcinoma
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 29, 2021

Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +7 more
  • IDO1 Inhibitor BMS-986205
  • Nivolumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Gastrointestinal Stromal Tumors Trial in Ann Arbor, New York (Pembrolizumab, Epacadostat)

Completed
  • Gastrointestinal Stromal Tumors
  • Ann Arbor, Michigan
  • +1 more
Mar 18, 2021

Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)

Recruiting
  • Lip
  • +4 more
  • Nivolumab
  • +3 more
  • Columbus, Ohio
  • +1 more
Oct 25, 2021

Breast Cancer, Lung Cancer, Melanoma Trial in Nashville (1-methyl-D-tryptophan)

Terminated
  • Breast Cancer
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University
May 26, 2020

Solid Tumor Trial in Gainesville, Saint Louis, Albuquerque (NLG802)

Completed
  • Solid Tumor
  • Gainesville, Florida
  • +2 more
Jun 3, 2020

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

Completed
  • Metastatic Melanoma
  • +2 more
  • Augusta, Georgia
  • +5 more
Jun 3, 2020

Glioblastoma Trial in Chicago (biological, radiation, drug)

Recruiting
  • Glioblastoma
  • IDO1 Inhibitor BMS-986205
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 30, 2020

Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer Trial in United States (Nab-Paclitaxel, Gemcitabine,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Cancer
  • Palo Alto, California
  • +10 more
May 26, 2020

Advanced Solid Tumors Trial in Zibo (DN1406131, Placebo)

Unknown status
  • Advanced Solid Tumors
  • Zibo, Shandong, China
    PKUCare Luzhong Hospital
Jul 31, 2019

Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor

Terminated
  • Glioblastoma
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Conformal Radiation)

Completed
  • Glioblastoma Multiforme
  • +7 more
  • Aurora, Colorado
  • +4 more
Jun 3, 2020

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Castro Valley, California
  • +16 more
May 26, 2020

Mediastinitis and Staphylococcus Aureus

Completed
  • Surgery, Cardiac
  • Infection
  • No intervention
  • Rennes, France
    Rennes Hospital University
Dec 13, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Metastatic Breast Cancer Trial in Poland, United States (Docetaxel, Placebo, Indoximod)

Completed
  • Metastatic Breast Cancer
  • Gainesville, Florida
  • +39 more
May 26, 2020

Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

Recruiting
  • Ependymoma
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
Dec 16, 2022

Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])

Enrolling by invitation
  • Lung Transplant; Complications
  • Etanercept Injection [Enbrel]
  • Chicago, Illinois
    Northwestern University
Jul 10, 2023

Ovarian Cancer, Genitourinary (GU) Tumors Trial in Worldwide (Epacadostat, tamoxifen)

Terminated
  • Ovarian Cancer
  • Genitourinary (GU) Tumors
  • La Jolla, California
  • +48 more
Mar 6, 2019

Advanced Solid Tumors Trial in Pittsburgh (Stereotactic Body Radiotherapy (SBRT), navoximod, NLG802 (indoximod Prodrug))

Not yet recruiting
  • Advanced Solid Tumors
  • Stereotactic Body Radiotherapy (SBRT)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 18, 2022

Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

Active, not recruiting
Has Results
  • Melanoma
  • FDG PET/CT scan
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Jan 10, 2023

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023